(Q41722677)

8 October 2017

1 reference

title

Transdermal testosterone (English)

1 reference

8 October 2017

McClellan KJ

1

1 reference

8 October 2017

Goa KL

series ordinal

2

1 reference

8 October 2017

publication date

1 February 1998

1 reference

8 October 2017

1 reference

8 October 2017

volume

55

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

253-8; discussion 259

1 reference

Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study

8 October 2017

cites work

1 reference

12 December 2020

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

12 December 2020

Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.

1 reference

12 December 2020

Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system

1 reference

12 December 2020

Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of dose.

1 reference

12 December 2020

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men

1 reference

12 December 2020

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

1 reference

12 December 2020

10.2165/00003495-199855020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1026630491

0 references

1 reference